As with in-hospital cardiovascular events (primary endpoint), significant differences were also observed in the secondary endpoints between the two groups, i.e., myocardial ischaemia, cTnI elevation, acute coronary event, heart failure, and arrhythmia requiring treatment. This evidence concerns the gene TNNI3 and heart failure.